Document is current
Any future updates will be listed below
-
Authors
Lin, Yunqing
Xiao, Ziyun
Hu, Fangxiao
Zheng, Xiujuan
Zhang, Chenyuan
Wang, Yao
Liu, Yanhong
Huang, Dehao
Wang, Zhiqian
Xia, Chengxiang
Weng, Qitong
Zhang, Leqiang
Zhao, Yaoqin
Qi, Hanmeng
Shen, Yiyuan
Chen, Yi
Zhang, Fan
Wu, Jiaxin
Liu, Pengcheng
Xu, Jiacheng
Liu, Lijuan
Zhu, Yanping
Zhang, Jingliao
Qian, Wenbin
Liang, Aibin
Zhu, Xiaofan
Wang, Tongjie
Zhang, Mengyun
Wang, Jinyong
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82300132, 82350104, 82470120, 82450001)
National Key Research and Development Program of China (2021YFA1100800, 2024YFA1108302)
Noncommunicable Chronic Diseases-National Science and Technology Major Project (2023ZD0501200)
R&D program of Beijing Escure Biotechnology Co., Ltd (E441O71131)
- License Information
-
More Information
Article History
Received: 23 January 2025
Accepted: 9 May 2025
First Online: 19 May 2025
Declarations
:
: Experiments and handling of mice were conducted under the Institutional Animal Care and Use Committee of the Institute of Zoology, Chinese Academy of Sciences. The studies involving humans were approved by the Biomedical Research Ethics Committee of the Institute of Zoology, Chinese Academy of Sciences. The use of patient samples was conducted in accordance with the provisions of the Declaration of Helsinki. All patient samples were collected with priori patient consent signatures and were reviewed and approved by the Ethics Committee of State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College.
: Not applicable.
: The authors declare no competing interests.
